BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 28441376)

  • 1. NUT Midline Carcinoma: A Rare Malignancy.
    Al Diffalha S; Al Aukla N; Hasan S; Dickinson S; Khalil F
    Cancer Control; 2017 Apr; 24(2):202-206. PubMed ID: 28441376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary pulmonary NUT midline carcinoma: An elusive and a rare diagnostic entity.
    Pasricha S; Jajodia A; Sharma A; Bansal D; Batra U; Gupta G; Durga G; Kamboj M; Nathany S; Mehta A
    J Cancer Res Ther; 2023; 19(3):816-818. PubMed ID: 37470617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NUT carcinoma - An aggressive thoracic tumor.
    Ribeiro JA; Sousa J; Jesus F; Almeida É; Costa JF; Reis M; Gomes RM
    Am J Med Sci; 2023 Jul; 366(1):64-70. PubMed ID: 37100347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NUT midline carcinoma in a young pregnant female: a case report.
    Joel S; Weschenfelder F; Schleussner E; Hofmann GO; Weschenfelder W
    World J Surg Oncol; 2020 Nov; 18(1):290. PubMed ID: 33160369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pulmonary nuclear protein of the testis midline carcinoma:a case report].
    Wang KJ; Xia QD; Ding F; Hu X; Liu BC
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Oct; 46(10):1019-1021. PubMed ID: 37752046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maxillary Sinus NUT Carcinoma: A Case Report.
    Arai S; Tomioka R; Ueda Y; Shimizu A; Okamoto I; Tsukahara K
    Cancer Diagn Progn; 2024; 4(3):370-378. PubMed ID: 38707725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunodetection of NUT Protein: Implementation, Indications, and Results in a Tertiary Reference Center.
    Noorwali H; Casiraghi O; Classe M; Adam J; Ngo C; Ghigna MR; Kanaan C; Khneisser P; Bani MA; Cotteret S; Scoazec JY
    Appl Immunohistochem Mol Morphol; 2024 Feb; 32(2):64-70. PubMed ID: 37972936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of a case with NUT midline carcinoma in the larynx and review of the literature.
    Zhang H; Liu MH; Zhang J; Luo SP; Wang CB; Zhao ZH; Ge YL; Zhang JY; Geng FH
    Clin Case Rep; 2020 Jan; 8(1):176-181. PubMed ID: 31998511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How Much Can We Bet on Activity of BET Inhibitors Beyond NUT-Midline Carcinoma?
    Martin-Romano P; Baldini C; Postel-Vinay S
    JNCI Cancer Spectr; 2020 Apr; 4(2):pkz092. PubMed ID: 32328560
    [No Abstract]   [Full Text] [Related]  

  • 10. NUT carcinoma in children and adults: A multicenter retrospective study.
    Lemelle L; Pierron G; Fréneaux P; Huybrechts S; Spiegel A; Plantaz D; Julieron M; Dumoucel S; Italiano A; Millot F; Le Tourneau C; Leverger G; Chastagner P; Carton M; Orbach D
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28643357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NUT Midline Carcinoma: A Series of Five Cases, Including One with Unusual Clinical Course.
    Kakkar A; Antony VM; Irugu DVK; Adhikari N; Jain D
    Head Neck Pathol; 2018 Jun; 12(2):230-236. PubMed ID: 28948459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rediagnosis of Lung Cancer as NUT Midline Carcinoma Based on Clues From Tumor Genomic Profiling.
    Baras AS; Naidoo J; Hann CL; Illei PB; Reninger CW; Lauring J
    J Natl Compr Canc Netw; 2018 May; 16(5):467-472. PubMed ID: 29752320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NUT Midline Carcinoma in the Mediastinum in a Ten-Year-Old Boy.
    Ma Y; Feng J; Xiao X; Chen L
    Arch Bronconeumol (Engl Ed); 2018 Oct; 54(10):539-541. PubMed ID: 29650254
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular-genetic profiling and high-throughput
    Stirnweiss A; Oommen J; Kotecha RS; Kees UR; Beesley AH
    Oncotarget; 2017 Dec; 8(68):112313-112329. PubMed ID: 29348827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncovering BRD4 hyperphosphorylation associated with cellular transformation in NUT midline carcinoma.
    Wang R; Cao XJ; Kulej K; Liu W; Ma T; MacDonald M; Chiang CM; Garcia BA; You J
    Proc Natl Acad Sci U S A; 2017 Jul; 114(27):E5352-E5361. PubMed ID: 28630312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NUT Carcinoma: Clinicopathologic features, pathogenesis, and treatment.
    French CA
    Pathol Int; 2018 Nov; 68(11):583-595. PubMed ID: 30362654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NUT Midline Carcinoma.
    Patil VM; Toshniwal A; Noronha V; Joshi A; Menon N; Banavali S; Prabhash K
    Clin Oncol (R Coll Radiol); 2019 Oct; 31(10):732. PubMed ID: 31331817
    [No Abstract]   [Full Text] [Related]  

  • 18. NUT midline carcinoma: Current concepts and future perspectives of a novel tumour entity.
    Salati M; Baldessari C; Bonetti LR; Messina C; Merz V; Cerbelli B; Botticelli A
    Crit Rev Oncol Hematol; 2019 Dec; 144():102826. PubMed ID: 31707223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Overview of Molecular Mechanism, Clinicopathological Factors, and Treatment in NUT Carcinoma.
    Huang QW; He LJ; Zheng S; Liu T; Peng BN
    Biomed Res Int; 2019; 2019():1018439. PubMed ID: 31815119
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.